Mereo BioPharma Group PLC ADR
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $361 |
Gross Profit | 0 | -257 | -274 | 144 |
EBITDA | -9,373 | -12,049 | -8,837 | -7,016 |
EBIT | -9,655 | -12,306 | -9,112 | -7,257 |
Net Income | -15,001 | -12,255 | -8,951 | -6,046 |
Net Change In Cash | 0 | 0 | 0 | 361 |
Free Cash Flow | -7,519 | -7,903 | -8,686 | -1,704 |
Cash | 80,522 | 87,431 | 48,660 | 57,421 |
Basic Shares | 770,146 | 142,354 | 700,263 | 691,820 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $10,000 | $1,507 | $36,464 | $393 |
Gross Profit | 7,426 | 571 | 18,556 | -15,954 |
EBITDA | -28,416 | -42,062 | -5,003 | -37,525 |
EBIT | -29,477 | -43,569 | -5,869 | -37,569 |
Net Income | -29,466 | -34,196 | 12,725 | -163,628 |
Net Change In Cash | 10,000 | 1,507 | 36,464 | 393 |
Free Cash Flow | -21,551 | -38,830 | -5,774 | -28,357 |
Cash | 57,421 | 56,334 | 94,296 | 23,469 |
Basic Shares | 659,453 | 603,196 | 555,275 | 338,953 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.09 |
2024-06-30 | -$0.08 |
2024-03-31 | -$0.06 |
2023-09-30 | $0 |
